Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Achelios Therapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Achelios Therapeutics

Achelios Therapeutics

Angel

Achelios Therapeutics, a US-based company, innovates superior tissue-penetrating NSAID products using proprietary technology.

HQ
Chapel Hill, NC, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Achelios Therapeutics, founded in Chapel Hill, United States, is dedicated to developing advanced NSAID products with superior tissue penetration using their proprietary ACHETOGEL™ delivery technology. Their core mission is to provide effective topical treatments for pain and inflammation, targeting conditions such as temporomandibular joint disorder (TMJD), menstrual migraines, and chronic inflammatory joint pain. Their lead product, TOPOFEN™, utilizes the NSAID ketoprofen and has demonstrated promising results in pre-clinical and early-stage clinical studies.

Achelios Therapeutics has garnered attention for its innovative approach to pain management, attracting notable investors and industry experts. The company's achievements include securing patents for their unique delivery technology and advancing TOPOFEN™ through critical stages of development. Their impact lies in offering non-invasive, effective alternatives to traditional pain relief methods, potentially improving the quality of life for individuals suffering from chronic pain conditions.

Achelios Therapeutics - Similar Companies

Akelos logo

Akelos

akelosinc.com

Exodos Life Sciences logo

Exodos Life Sciences

exodosls.com

Isosceles Pharmaceuticals logo

Isosceles Pharmaceuticals

Concentric Analgesics logo

Concentric Analgesics

Amalgent Therapeutics logo

Amalgent Therapeutics

amalgent.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Aiko Biotechnology logo

Aiko Biotechnology

Arch Therapeutics logo

Arch Therapeutics

EicOsis logo

EicOsis

eicosis.com

Sollis Therapeutics logo

Sollis Therapeutics

Novel Therapeutic Technologies logo

Novel Therapeutic Technologies

ntt-inc.com

Doloromics logo

Doloromics

doloromics.com

Aether Therapeutics logo

Aether Therapeutics

Acylin Therapeutics logo

Acylin Therapeutics

Latigo Biotherapeutics logo

Latigo Biotherapeutics

latigobio.com

Achelios Therapeutics - Quick Facts

Who are Achelios Therapeutics' competitors?

Companies similar to Achelios Therapeutics include Akelos, Exodos Life Sciences, Isosceles Pharmaceuticals and Concentric Analgesics.

When was Achelios Therapeutics founded?

Achelios Therapeutics was founded in 2012.

Where is Achelios Therapeutics' headquarters located?

Achelios Therapeutics' headquarters is located in Chapel Hill, NC, US.

When was Achelios Therapeutics' last funding round?

Achelios Therapeutics' most recent funding round was for $350k (USD) in April 2016.

How much has Achelios Therapeutics raised to-date?

As of Apr 19, 2016, Achelios Therapeutics has raised a total of $3.5M (USD).

How many employees does Achelios Therapeutics have?

Achelios Therapeutics has 5 employees as of Feb 5, 2024.

Achelios Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
Customer
  • Small Business
Main Product
  • NSAID Products
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified